Bronchiectasis pathophysiology: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(9 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Bronchiectasis}}
{{Bronchiectasis}}
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D.
{{CMG}}; {{AE}} {{HQ}}, Saarah T. Alkhairy, M.D.


==Overview==
==Overview==
Line 9: Line 9:
The following events summarize the pathophysiology of bronchiectasis:<ref>{{cite journal |author=Morrissey BM |title=Pathogenesis of bronchiectasis |language=English |journal=Clin Chest Med|volume=28 |issue=2 |pages=289-96 |year=2007 |pmid=17467548 |doi=}}</ref>
The following events summarize the pathophysiology of bronchiectasis:<ref>{{cite journal |author=Morrissey BM |title=Pathogenesis of bronchiectasis |language=English |journal=Clin Chest Med|volume=28 |issue=2 |pages=289-96 |year=2007 |pmid=17467548 |doi=}}</ref>


*[[Dilation]] of the [[bronchial]] walls results in airflow obstruction and impaired clearance of secretions  
*[[Dilation]] of the [[bronchial]] walls results in airflow obstruction and impaired clearance of secretions.
*The dilated areas interrupt normal air pressure of the [[bronchial]] tubes, causing [[sputum]] to pool inside the dilated areas instead of being pushed upward.  
*The dilated areas interrupt normal air pressure of the [[bronchial]] tubes, causing [[sputum]] to pool inside the dilated areas instead of being pushed upward.  
*The sputum contains [[elastase]], [[interleukin-8]], [[tumor necrosis factor alpha]] ([[Tumor necrosis factor-alpha|TNF-a]]), and prostanoids
*The sputum contains [[elastase]], [[interleukin-8]], [[tumor necrosis factor alpha]] ([[Tumor necrosis factor-alpha|TNF-a]]), and [[Prostanoid|prostanoids]].
*The pooled [[sputum]] provides an environment favorable to the growth of infectious [[pathogen|pathogens]]
*The pooled [[sputum]] provides an environment favorable to the growth of infectious [[pathogen|pathogens]].
*Recurrent [[Infection|infections]] are followed [[inflammation]] and infiltration of [[Neutrophil|neutrophils]], [[Macrophage|macrophages]], and [[T cell|T-lymphocytes]]
*Recurrent [[Infection|infections]] are followed [[inflammation]] and infiltration of [[Neutrophil|neutrophils]], [[Macrophage|macrophages]], and [[T cell|T-lymphocytes]].
*The more [[infections]] that the [[Lung|lungs]] experience, the more inflammation they sustain, and the more damaged the [[alveoli]] in the [[lung]] become
*The more [[infections|infection]] that the [[Lung|lungs]] experience, leads to the sustained inflammation, consequently, damage to the [[alveoli]] in the [[lung|lungs]].
*With more injury to the [[lung]] tissue, the elasticity in the [[bronchial tube]]s is reduced and the tubes are dilated, which creates a perpetual destructive cycle
*With more injury to the [[lung]] tissue, the elasticity in the [[bronchial tube]]s is reduced and the tubes are dilated, which creates a perpetual destructive cycle


===Cole's Cycle===
===Cole's Cycle===
The following events summarize Cole's cycle (Cole's "vicious cycle hypothesis"), which is the most widely known model of the development of bronchiectasis :<ref name="pmid20037680">{{cite journal| author=King PT| title=The pathophysiology of bronchiectasis. | journal=Int J Chron Obstruct Pulmon Dis | year= 2009 | volume= 4 | issue=  | pages= 411-9 | pmid=20037680 | doi= | pmc=PMC2793069 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20037680  }} </ref>
The following events summarize Cole's cycle (Cole's "vicious cycle hypothesis"), which is the most widely known model of the development of bronchiectasis:<ref name="pmid20037680">{{cite journal| author=King PT| title=The pathophysiology of bronchiectasis. | journal=Int J Chron Obstruct Pulmon Dis | year= 2009 | volume= 4 | issue=  | pages= 411-9 | pmid=20037680 | doi= | pmc=PMC2793069 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20037680  }} </ref>
*Two factors required for the development of bronchiectasis, namely persistent [[infection]] and host defense derangement
*Two factors are required for the development of bronchiectasis:
*Impaired mucociliary clearance due to genetic susceptibility causes environmental insult
**Persistent [[infection]]  
*Insults result in persistence of microbes in the sinobronchial tree  
**Host defense derangement
*The microbial [[infection]] causes chronic [[inflammation]], which results in tissue damage and impaired [[Mucociliary clearance|mucociliary]] motility.
*Impaired mucociliary clearance due to the genetic susceptibility may cause environmental insult.
*Insults result in persistence of microbes in the sinobronchial tree.
*The microbial [[infection]] can cause chronic [[inflammation]], which may result in tissue damage and impaired [[Mucociliary clearance|mucociliary]] motility.
*[[Inflammation]] ensues more [[infection]], which in turn ensues more [[inflammation]].
*[[Inflammation]] ensues more [[infection]], which in turn ensues more [[inflammation]].


===Immune Response===
===Immune Response===
*Bronchiectasis involves the activity of [[reactive oxygen species]] (ROS), elastases, and matrix metalloproteases (MMP):
*Bronchiectasis involves the activity of [[reactive oxygen species]] ([[Reactive oxygen species|ROS]]), [[Elastase|elastases]], and [[Matrix metalloproteinase|matrix metalloproteinases]] ([[MMP|MMPs]]):
**[[Reactive oxygen species]] (ROS)
**[[Reactive oxygen species]] ([[Reactive oxygen species|ROS]])
***A by product for the metabolism of [[oxygen]]
***A by product for the metabolism of [[oxygen]]
***Increased concentration may result in cell structure damage
***Increased concentration may result in cell structure damage


* [[Elastase]]
* [[Elastase]]
** [[Protease]] that catalyzes the breaks down of [[elastin]]
** [[Protease]] that catalyzes the breaks down of [[elastin]].
** [[Elastin]] plus [[collagen]] determine the mechanical properties of [[connective tissue]]
** [[Elastin]] plus [[collagen]] determine the mechanical properties of [[connective tissue]].


* [[Matrix metalloproteinases]] (MMPs)
* [[Matrix metalloproteinases]] ([[Matrix metalloproteinase|MMPs]])
** Responsible for the degradation of the majority of the extracellular proteins during normal tissue turnover
** Responsible for the degradation of the majority of the extracellular proteins during normal tissue turn over.
** [[Inflammation]] may result in epithelial injury and [[mucus]] secretion via increased concentrations of ROS, [[elastase]] ciliotoxin, and [[mucus]] secretogogues
** [[Inflammation]] may result in epithelial injury and [[mucus]] secretion via increased concentrations of [[Reactive oxygen species|ROS]], [[elastase]] ciliotoxin, and [[mucus]] secretogogues.
** [[Epithelial]] injury and [[mucus]] hypersecretion lead to chronic [[bronchial]] infection, reduced [[mucociliary clearance]], and plugging of the [[airway]] - which all eventually leads to airway damage and bronchiectasis
** [[Epithelial]] injury and [[mucus]] hypersecretion lead to chronic [[bronchial]] infection, reduced [[mucociliary clearance]], and plugging of the [[airway]] - which all eventually leads to airway damage and bronchiectasis.


The diagram below depicts the immune response for bronchiectasis
The diagram below depicts the immune response for bronchiectasis:
<gallery widths="200px">
<gallery widths="200px">
F1.large.jpg | Schematic representation of a vicious circle of events which occurs during chronic bronchial infection. IL: interleukin; TNF: tumour necrosis factor; LT: leukotriene; MMP: matrix metalloproteinase <br> [http://erj.ersjournals.com/content/31/2/396/F1.large.jpg <font size="-2">''European Respiratory Journal''</font>]
F1.large.jpg | Schematic representation of a vicious circle of events which occurs during chronic bronchial infection. IL: interleukin; TNF: tumour necrosis factor; LT: leukotriene; MMP: matrix metalloproteinase <br> [http://erj.ersjournals.com/content/31/2/396/F1.large.jpg <font size="-2">''European Respiratory Journal''</font>]
</gallery>
</gallery>


====Gross Pathology====
==Gross Pathology==
[[File:Bronchiectasis-gross-pathology-1.jpg|thumb|left|369x369px|Bronchiectasis [https://radiopaedia.org/cases/bronchiectasis-gross-pathology-1 Source:Case courtesy of Dr Yale Rosen, Radiopaedia.org, rID: 9307]]]
[[File:Bronchiectasis-gross-pathology-1.jpg|thumb|left|369x369px|Bronchiectasis [https://radiopaedia.org/cases/bronchiectasis-gross-pathology-1 Source:Case courtesy of Dr Yale Rosen, Radiopaedia.org, rID: 9307]]]
<br clear="left" />
<br clear="left" />
Line 52: Line 54:
{{Reflist|2}}
{{Reflist|2}}


 
​​
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WH}}
{{WS}}


[[Category:Pulmonology]]
[[Category:Pulmonology]]
[[Category:Emergency medicine]]
[[Category:Medicine]]
[[Category:Up-To-Date]]

Latest revision as of 20:43, 29 July 2020

Bronchiectasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bronchiectasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bronchiectasis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bronchiectasis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bronchiectasis pathophysiology

CDC on Bronchiectasis pathophysiology

Bronchiectasis pathophysiology in the news

Blogs on Bronchiectasis pathophysiology

Directions to Hospitals Treating Bronchiectasis

Risk calculators and risk factors for Bronchiectasis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2], Saarah T. Alkhairy, M.D.

Overview

Bronchiectasis involves cycles of infections and inflammation that result in alveolar damage and inelastic dilated bronchi. Damage to the airway results in airflow obstruction and impaired clearance of secretions.

Pathophysiology

The following events summarize the pathophysiology of bronchiectasis:[1]

Cole's Cycle

The following events summarize Cole's cycle (Cole's "vicious cycle hypothesis"), which is the most widely known model of the development of bronchiectasis:[2]

  • Two factors are required for the development of bronchiectasis:
    • Persistent infection
    • Host defense derangement
  • Impaired mucociliary clearance due to the genetic susceptibility may cause environmental insult.
  • Insults result in persistence of microbes in the sinobronchial tree.
  • The microbial infection can cause chronic inflammation, which may result in tissue damage and impaired mucociliary motility.
  • Inflammation ensues more infection, which in turn ensues more inflammation.

Immune Response

The diagram below depicts the immune response for bronchiectasis:

Gross Pathology

Bronchiectasis Source:Case courtesy of Dr Yale Rosen, Radiopaedia.org, rID: 9307


References

  1. Morrissey BM (2007). "Pathogenesis of bronchiectasis". Clin Chest Med. 28 (2): 289–96. PMID 17467548.
  2. King PT (2009). "The pathophysiology of bronchiectasis". Int J Chron Obstruct Pulmon Dis. 4: 411–9. PMC 2793069. PMID 20037680.

​​ ​ Template:WH Template:WS